ms 857 has been researched along with Heart Failure in 2 studies
*Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iwase, M; Nagata, K; Sobue, T; Yokota, M | 1 |
| Kaiho, T; Kamiya, J; Kobari, T; Maruyama, M | 1 |
1 trial(s) available for ms 857 and Heart Failure
| Article | Year |
|---|---|
Differential effects of dobutamine and a phosphodiesterase inhibitor on early diastolic filling in patients with congestive heart failure.
Topics: Administration, Oral; Blood Flow Velocity; Cardiac Catheterization; Coronary Circulation; Diastole; Dobutamine; Echocardiography, Doppler, Pulsed; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Isoquinolines; Male; Middle Aged; Phosphodiesterase Inhibitors; Tetrahydroisoquinolines; Ventricular Function, Left | 1995 |
1 other study(ies) available for ms 857 and Heart Failure
| Article | Year |
|---|---|
Cardiovascular properties of MS-857, a new and potent cardiotonic agent, on normal and failing hearts.
Topics: Anesthesia; Animals; Cardiotonic Agents; Dogs; Female; Heart; Heart Failure; Isoquinolines; Lung; Male; Myocardium; Pentobarbital; Phosphoric Diester Hydrolases; Propranolol; Sodium-Potassium-Exchanging ATPase; Stereoisomerism; Tetrahydroisoquinolines | 1988 |